SirReal1-O-propargyl

Target: This ligand targets sirtuin 2 (SIRT2) in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for sirtuin 2 (SIRT2). In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings sirtuin 2 (SIRT2) into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC Ligand for E3 Recruitment: SirReal1-O-propargyl can be used as a reactive handle to build PROTACs that recruit an E3 ubiquitin ligase via a covalent or proximity-enabled linkage strategy. In targeted protein degradation studies, this enables systematic testing of linker geometries and attachment positions to tune ubiquitination efficiency and degradation potency.

• Modular PROTAC Synthesis Platform: The propargyl functionality supports modular conjugation, allowing rapid synthesis of chimeric degraders where SirReal1-O-propargyl serves as a ligand component. Researchers can generate structure–activity series by varying linker length and rigidity, then assess target engagement, ubiquitin recruitment, and degradation kinetics across cell-based or biochemical assays.

• Targeted Degrader Optimization Studies: Incorporating SirReal1-O-propargyl into PROTAC architectures facilitates optimization of degraders designed to maximize target turnover rather than occupancy alone. By comparing degradation profiles under different linker and conjugation chemistries, investigators can identify designs that promote efficient ubiquitination, proteasomal processing, and sustained reduction of the target protein.

• Mechanistic Probing of Degradation: SirReal1-O-propargyl-based PROTACs can be used to dissect degradation mechanisms, including dependence on E3 ligase recruitment and proteasome activity. Experimental designs may include inhibitor perturbations, time-course degradation measurements, and ubiquitination readouts to determine whether the chimeric construct drives productive ubiquitin chain formation and rapid target clearance.

SirReal1-O-propargyl is a SIRT2 ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of SirReal1-O-propargyl is characterized by amide/urea/sulfonamide hydrogen-bonding motifs; alkyne or click-compatible unsaturation; heteroaromatic protein-recognition scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The alkyne/propargyl functionality is suitable for azide-alkyne cycloaddition or related click-linker exploration. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.